Dr Prithipal Singh is based in the Silicon Valley, and is a pioneer in the medical devices arena. His last product was launched by President Bill Clinton at the White House. Dr. Prithipal holds over 40 US patents and over 200 worldwide. Dr Prithipal Singh currently serves on the Board of Directors of Abaxis, Inc. Dr. Prithal has been Vice President at Syntex Corporation, Executive Vice President of Idetec Corporation and a Vice President of Syva Corporation. After his years in the corporate world, Dr Singh turned entrepreneur and founded ChemTrak Inc (funded by Sequoia Capital) amongst other companies. He became the first Indian to take a Biomedical Company public on NASDAQ stock exchange in 1992. Dr Singh holds a Doctorate from the University of Toronto and did his Post doctorate from University of South Hampton.